SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950133-97-003302
Filing Date
1997-09-18
Accepted
1997-09-18 00:00:00
Documents
4
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 ALEXION PHARMACEUTICALS, INC. SCHEDULE 13D SC 13D 23952
2 POWER OF ATTORNEY IN FAVOR OF DR. ANDREAS BREMER EX-1 4671
3 POWER OF ATTORNEY IN FAVOR OF DR. ANDREAS HOVE EX-2 4453
4 JOINT FILING AGREEMENT EX-4 1739
  Complete submission text file 0000950133-97-003302.txt   37194
Mailing Address 25 SCIENCE PARK STE 360 NEW HAVEN CT 06511
Business Address 25 SCIENCE PARK STE 360 NEW HAVEN CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13D | Act: 34 | File No.: 005-47771 | Film No.: 97682617
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000